ReDLat2

SPEAKER

Anne Alward is the Head of Business Development for the Bluefield Project to Cure FTD. She has more than 25 years of BD experience in the life sciences industry across non-profit, biotech and pharmaceutical sectors.

Anne Alward is the Head of Business Development for the Bluefield Project to Cure FTD. She has more than 25 years of BD experience in the life sciences industry across non-profit, biotech and pharmaceutical sectors.Anne Alward is the Head of Business Development for the Bluefield Project to Cure FTD. She has more than 25 years of BD experience in the life sciences industry across non-profit, biotech and pharmaceutical sectors.

She has structured and negotiated multiple strategic collaborations as well as industry – academic partnerships and licenses. For Bluefield she leads the negotiation and structuring of Bluefield’s academic grants and infrastructure initiatives.

MODERATOR

Enzo Tagliazucchi studied Physics at the University of Buenos Aires and earned his PhD in Neuroscience at the University of Frankfurt, Germany.

Enzo Tagliazucchi studied Physics at the University of Buenos Aires and earned his PhD in Neuroscience at the University of Frankfurt, Germany.

He received AXA, Marie Curie, and DFG Mercator fellowships and worked at the Netherlands Institute for Neuroscience and the Brain and Spine Institute in Paris. His research explores healthy and pathological brain states, particularly those involving altered consciousness and self-awareness, including sleep, anesthesia, dementia, and disorders of consciousness. He leads a multidisciplinary team combining theoretical and computational neuroscience, machine learning, data science, and computational neuropsychiatry, bringing this expertise to BrainLat and its mission.

MODERATOR

Carolina Ochoa-Rosales is a Lead Investigator at BrainLat whose research explores genetic, epigenetic, and molecular mechanisms linking lifestyle, pharmacological, and socioeconomic factors to age-related health outcomes.

Carolina Ochoa-Rosales is a Lead Investigator at BrainLat whose research explores genetic, epigenetic, and molecular mechanisms linking lifestyle, pharmacological, and socioeconomic factors to age-related health outcomes.

She combines genomic, epigenomic, and transcriptomic markers with advanced biostatistical methods in diverse population studies, including the Rotterdam Study, UK Biobank, Framingham Heart Study, and Chilean National Health Survey. Her work focuses on genomic and epigenomic diversity in mental and cognitive health among underrepresented populations, examining how environmental determinants influence these outcomes. She has published in leading scientific journals, received scientific honours and scholarships, and serves as a peer reviewer for international journals.

Carolina Ochoa-Rosales is a Lead Investigator at BrainLat whose research explores genetic, epigenetic, and molecular mechanisms linking lifestyle, pharmacological, and socioeconomic factors to age-related health outcomes. She combines genomic, epigenomic, and transcriptomic markers with advanced biostatistical methods in diverse population studies, including the Rotterdam Study, UK Biobank, Framingham Heart Study, and Chilean National Health Survey. Her work focuses on genomic and epigenomic diversity in mental and cognitive health among underrepresented populations, examining how environmental determinants influence these outcomes. She has published in leading scientific journals, received scientific honours and scholarships, and serves as a peer reviewer for international journals.

SPEAKER

Adolfo García, Ph.D., specializes in the neuroscience of language. He directs the Cognitive Neuroscience Center at Universidad de San Andrés, Argentina, and is a Senior Fellow at the Global Brain Health Institute, University of California, San Francisco.

Adolfo García, Ph.D., specializes in the neuroscience of language. He directs the Cognitive Neuroscience Center at Universidad de San Andrés, Argentina, and is a Senior Fellow at the Global Brain Health Institute, University of California, San Francisco.

He also serves as an Associate Researcher at Universidad de Santiago de Chile. He co-founded Include, a global network for crosslinguistic brain health research, and created TELL, a speech testing app. His research includes a USD 8.3 million NIH grant on linguistic markers of dementia. He has authored over 200 publications. His contributions have earned international recognition, including the Society for the Neurobiology of Language’s Early Career Award and the World Economic Forum’s UpLink Top Innovator Award.

SPEAKER

Adrián Noriega de la Colina, M.D., Ph.D., is the MIT-Novo Nordisk AI Fellow at the Broad Institute of MIT and Harvard, MIT’s Department of Mechanical Engineering, and Brigham and Women’s Hospital.

Adrián Noriega de la Colina, M.D., Ph.D., is the MIT-Novo Nordisk AI Fellow at the Broad Institute of MIT and Harvard, MIT’s Department of Mechanical Engineering, and Brigham and Women’s Hospital.

His research combines multimodal AI and precision biomarkers to advance individualized prevention of Alzheimer’s disease. Trained in vascular and behavioral neurosciences at McGill University and the Montreal Neurological Institute-Hospital, he co-leads FINGERPRINT, an initiative integrating multiomic data for personalized prevention. He has been recognized as a World Heart Federation Emerging Leader and VA-MIT Catalyst Fellow, and is a Forbes Technology Council member. He has also served on the editorial boards of Stroke, CJC Open, and the Canadian Journal of Cardiology.

SPEAKER

Agustin Ibanez is Director of BrainLat at Universidad Adolfo Ibáñez, Professor of Global Brain Health at Trinity College Dublin, Senior Atlantic Fellow at GBHI–UCSF, Senior Researcher at Universidad de San Andrés, and Scientific and Strategy Director of Core Scientific Assets at the Barcelonaβeta Brain Research Center.

Agustin Ibanez is Director of BrainLat at Universidad Adolfo Ibáñez, Professor of Global Brain Health at Trinity College Dublin, Senior Atlantic Fellow at GBHI–UCSF, Senior Researcher at Universidad de San Andrés, and Scientific and Strategy Director of Core Scientific Assets at the Barcelonaβeta Brain Research Center.

His research advances precision brain health through biomarkers, neuroimaging, and AI. He has led or co-led major international initiatives supported by NIH/NIA, Wellcome Trust, the European Union, Alzheimer’s Association, Rainwater Charitable Foundation, GBHI, and ANID. He founded and helped lead ReDLat/ReDLat2 and LAC-CD, and holds leading roles in CliCBrain and MIBrain. He has published over 500 scientific papers, pioneering dementia research across diverse and underrepresented populations.

SPEAKER

Agustina Legaz, PhD, is a neuroscientist, and affiliated researcher and professor at the Department of Life and Behavioral Sciences, Universidad de San Andrés, Argentina. Her research examines how the exposome shapes brain health and dementia across Latin America and globally.

Agustina Legaz, PhD, is a neuroscientist, and affiliated researcher and professor at the Department of Life and Behavioral Sciences, Universidad de San Andrés, Argentina. Her research examines how the exposome shapes brain health and dementia across Latin America and globally.

She integrates neuroimaging, cognitive and clinical data, and machine-learning approaches, with a particular interest in translating exposome evidence into locally grounded prevention strategies and interventions. She is an Atlantic Fellow for Equity in Brain Health from the Global Brain Health Institute. Her research has been published in Nature Medicine, Nature Aging, and Brain, among others.

SPEAKER

Dr. Sosa is a psychiatrist with a PhD in Epidemiological Psychiatry from King’s College London, specializing in psychogeriatrics and dementia.

Dr. Sosa is a psychiatrist with a PhD in Epidemiological Psychiatry from King’s College London, specializing in psychogeriatrics and dementia.

She is a medical sciences researcher at Mexico’s National Institute of Neurology and Neurosurgery, where she founded and heads the Dementia Clinic and Laboratory of Dementias. For 25 years, she has served as Mexico’s Principal Investigator for the International 10/66 Dementia Research Group and collaborates with LatAm FINGERS and DIAN LatAm. A professor at the National Autonomous University of Mexico for 45 years, she also founded a postgraduate course on cognitive aging and dementia. She is a member of the Mexican Academy of Medicine and an emeritus researcher in Mexico’s National System of Researchers.

SPEAKER

Andrea Slachevsky, MD, PhD, is a cognitive and behavioral neurologist and Associate Professor at the University of Chile. She leads the Memory and Neuropsychiatric Center and is a principal investigator at the Center for Geroscience, Brain Health, and Metabolism (GERO).

Andrea Slachevsky, MD, PhD, is a cognitive and behavioral neurologist and Associate Professor at the University of Chile. She leads the Memory and Neuropsychiatric Center and is a principal investigator at the Center for Geroscience, Brain Health, and Metabolism (GERO).

She directs REMEMVER, a real-world data platform supported by the Alzheimer’s Association’s ALZ-NET International network, and leads a Chilean ReDLat site. Her research focuses on functional abilities across the cognitive impairment continuum. She founded COPRAD to promote dementia awareness and contributed to Chile’s National Dementia Plan, including its first public hospital Memory Clinic. She has published over 100 peer-reviewed articles and co-edited five books on cognitive disorders and dementia.

SPEAKER

anGie seah is a Singaporean multidisciplinary artist whose practice spans drawing, installation, performance, sculpture, and video. Her work connects art, brain health, ageing, and inclusion through community engagement with older adults, people living with dementia, and underrepresented groups.

anGie seah is a Singaporean multidisciplinary artist whose practice spans drawing, installation, performance, sculpture, and video. Her work connects art, brain health, ageing, and inclusion through community engagement with older adults, people living with dementia, and underrepresented groups.

An Atlantic Fellow at Trinity College Dublin (2025–2026), she explores equity in brain health and collaboration between artists and scientists. She has presented internationally at institutions including Palais de Tokyo, ZKM Center for Art and Media, Fukuoka Asian Art Museum, and the Asia Society Triennial. She founded the experimental music ensemble Qianpima and directs the Islands Time-Based Art Festival. She is developing an Art × Brain Health Festival in Singapore for 2028.

SPEAKER

Dr. Arcadi Navarro is CEO of the Pasqual Maragall Foundation and the Barcelonaβeta Brain Research Center. He is Professor of Genetics at Pompeu Fabra University, an ICREA researcher, and co-director of the European Genome-phenome Archive (EGA).

Dr. Arcadi Navarro is CEO of the Pasqual Maragall Foundation and the Barcelonaβeta Brain Research Center. He is Professor of Genetics at Pompeu Fabra University, an ICREA researcher, and co-director of the European Genome-phenome Archive (EGA).

He previously served as Secretary for Universities and Research of the Government of Catalonia, Director of Pompeu Fabra University’s Department of Experimental and Health Sciences, Deputy Director of the Institute of Evolutionary Biology (UPF-CSIC), and Director of the Population Genomics node of the Spanish National Bioinformatics Institute. He earned his PhD at the Autonomous University of Barcelona and completed his postdoctoral training at the University of Edinburgh.

SPEAKER

Belén Custodio holds a Master’s in Public Health and is Community Engagement Leader at the Instituto Peruano de Neurociencias in Lima, Peru. She develops community engagement and participant recruitment strategies for dementia studies in collaboration with community advisory boards.

Belén Custodio holds a Master’s in Public Health and is Community Engagement Leader at the Instituto Peruano de Neurociencias in Lima, Peru. She develops community engagement and participant recruitment strategies for dementia studies in collaboration with community advisory boards.

Her work is expanding to Aymara and Quechua communities in Puno, southern Peru, to increase research participation among historically underrepresented and vulnerable populations. She also co-founded Lonchecito para Cuidadores, an association supporting family caregivers of people with dementia in Peru since 2020. Her work connects research, caregiver support, and public engagement to strengthen community-centred dementia research across Latin America.

SPEAKER

Burcin Ikiz, PhD, is a neuroscientist and global health researcher studying how climate change and environmental exposures affect brain health across the lifespan.

Burcin Ikiz, PhD, is a neuroscientist and global health researcher studying how climate change and environmental exposures affect brain health across the lifespan.

She is an Adjunct Professor of Psychiatry and Behavioral Sciences at Stanford University and a research affiliate at the Stanford Center for Innovation in Global Health. She founded and chairs the International NeuroClimate Working Group and is founder and director of EcoNeuro. Her work integrates neuroscience, planetary health, and public policy, focusing on extreme heat, air pollution, climate disasters, and resilience. She advises the World Health Organization and UNICEF on climate, environmental health, and brain health, and was named one of Grist’s 50 leading climate innovators in 2025.

SPEAKER

Claudia Duran-Aniotz is a neuroscientist and Director of the Latin American Brain Health Institute (BrainLat) at Universidad Adolfo Ibáñez, Chile.

Claudia Duran-Aniotz is a neuroscientist and Director of the Latin American Brain Health Institute (BrainLat) at Universidad Adolfo Ibáñez, Chile.

Her research focuses on Alzheimer’s disease and other neurodegenerative disorders, with particular attention to Latin American populations. She bridges basic and clinical research to advance translational discoveries and strengthen collaborations in dementia research. Her work includes international studies validating novel biomarkers for early diagnosis and exploring therapies for Alzheimer’s disease. She is actively involved in regional initiatives, including the Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat) and the Latin American and Caribbean Consortium on Dementia (LAC-CD).

SPEAKER

Dr. David Aguillón is a physician-scientist, Lecturer in Physiology and Neurosciences at the University of Antioquia, and General Coordinator of the Grupo de Neurociencias de Antioquia (GNA).

Dr. David Aguillón is a physician-scientist, Lecturer in Physiology and Neurosciences at the University of Antioquia, and General Coordinator of the Grupo de Neurociencias de Antioquia (GNA).

He oversees clinical and research activities, including international trials on autosomal dominant Alzheimer’s disease associated with the PSEN1 E280A mutation. His research explores early biomarkers, genetic variants, and resilience, including contributions to studies of p-tau217, APOE3 Christchurch, and RELN-COLBOS. His work integrates clinical, biomarker, genetic, and computational approaches to advance Alzheimer’s prevention and treatment. He also cares for patients with neurodegenerative disorders and mentors future neuroscience researchers.

SPEAKER

Diana Matallana is a psychologist with graduate training in Experimental Neuropsychology and a Full Professor at Pontificia Universidad Javeriana’s Faculty of Medicine in Bogotá, Colombia.

Diana Matallana is a psychologist with graduate training in Experimental Neuropsychology and a Full Professor at Pontificia Universidad Javeriana’s Faculty of Medicine in Bogotá, Colombia.

Her clinical and research expertise focuses on cognition in normal aging, mental health, social cognition, and neurodegenerative diseases, particularly early-onset Alzheimer’s disease and frontotemporal dementia (FTD). In 1992, she co-founded the Memory and Cognition Clinic (MCC-Intellectus) at Hospital Universitario San Ignacio, which provides interdisciplinary diagnosis and care. Supported by university funding and two Fogarty grants, she has investigated early-onset FTD and contributed to identifying associated genetic variants in Colombia. Her contributions to ReDLat draw on extensive experience studying patients and families across the country.

SPEAKER

Dr. Ré, Associate Professor of Environmental Health Sciences at Columbia University, is a neuroscientist focused on investigating how environmental exposures intersect with genetic risk factors to impact brain health.

Dr. Ré, Associate Professor of Environmental Health Sciences at Columbia University, is a neuroscientist focused on investigating how environmental exposures intersect with genetic risk factors to impact brain health.

Dr. Ré is dedicated to transforming the prevention and treatment of neurodegenerative diseases through innovative gene-environment interaction mechanistic and biomarker studies. Currently, through international collaborative research, she is developing novel biomarkers to map blood-brain barrier damage and neurodegeneration caused by extreme heat events and air pollution.

SPEAKER

Eduardo Zimmer is head of Research at Hospital Moinhos de Vento (Brazil), Assistant Professor at the Federal University of Rio Grande do Sul (Brazil), and Adjunct Professor at McGill University (Canada).

Eduardo Zimmer is head of Research at Hospital Moinhos de Vento (Brazil), Assistant Professor at the Federal University of Rio Grande do Sul (Brazil), and Adjunct Professor at McGill University (Canada).

He is a CNPq Productivity Fellow (Level B) and a grantee of the Serrapilheira Institute and Ciência Pioneira programs. He is the recipient of the Alzheimer’s Association One-to-Watch Award (2021) and the Blas Frangione Early Career Achievement Award (2024). He has authored over 150 scientific publications and has extensive experience in both experimental and clinical research on Alzheimer’s disease.

SPEAKER

Dr Eimear McGlinchey is an Assistant Professor in Intellectual Disability at Trinity College Dublin and faculty member at the Global Brain Health Institute.

Dr Eimear McGlinchey is an Assistant Professor in Intellectual Disability at Trinity College Dublin and faculty member at the Global Brain Health Institute.

Her research focuses on Down syndrome associated with Alzheimer’s disease, leading projects across Europe and Africa focused on biomarkers, resilience and equity.

SPEAKER

Elisa Resende received her medical school training from the Universidade Federal de Minas Gerais, Brazil. She received her PhD in Neuroscience at the same University.

Elisa Resende received her medical school training from the Universidade Federal de Minas Gerais, Brazil. She received her PhD in Neuroscience at the same University.

Elisa did her residency in Neurology at the Hospital das Clínicas-UFMG/EBSERH. After one year of fellowship in Behavioral Neurology and Movement Disorders, she joined the hospital staff as assistant physician. She is an Atlantic Fellow for Equity in Brain Health and teaches behavioral neurology at Faculdade de Medicina de Ciências Médicas de Minas Gerais

SPEAKER

Executive Director & Board Member – Walking the Talk for Dementia. Journalist, Senior Atlantic Fellow for Equity in Brain Health at Global Brain Health Institute (GBHI) – Trinity College Dublin (TCD), and Director of Institutional Development at the International Longevity Centre Brazil (ILC-BR). 

Executive Director & Board Member – Walking the Talk for Dementia. Journalist, Senior Atlantic Fellow for Equity in Brain Health at Global Brain Health Institute (GBHI) – Trinity College Dublin (TCD), and Director of Institutional Development at the International Longevity Centre Brazil (ILC-BR). 

Author of five books on dementia, with nearly 500,000 copies sold. A three-time TEDx speaker, Senior Fellow of the U.S. Department of State’s Young Leaders of the Americas Initiative (YLAI). Fernando’s work is deeply shaped by his personal experience as a care partner to his grandmother during his adolescence. His interests and expertise span clinical communication, community building, and storytelling as tools for connection, advocacy, and systemic change.

SPEAKER

Glòria Oliver is Deputy CEO of the Pasqual Maragall Foundation. She is President of the Spanish Fundraising Association, First Vice-President of the Catalan Coordinating Body of Foundations, a trustee of the Catalunya La Pedrera Foundation, and Secretary of Catalonia’s Council for Research Philanthropy.

Glòria Oliver is Deputy CEO of the Pasqual Maragall Foundation. She is President of the Spanish Fundraising Association, First Vice-President of the Catalan Coordinating Body of Foundations, a trustee of the Catalunya La Pedrera Foundation, and Secretary of Catalonia’s Council for Research Philanthropy.

She also serves on the Social Council of the Polytechnic University of Catalonia and the General Conference of the Interuniversity Council of Catalonia, and co-founded EJE&CON. She holds a degree in Economics from Pompeu Fabra University, with postgraduate training in taxation, leadership, and science management, as well as executive training in senior management at ESADE.

SPEAKER

Dr. Hernando Santamaría García is a researcher in neurodegenerative diseases and brain health affiliated with Hospital Universitario San Ignacio.

Dr. Hernando Santamaría García is a researcher in neurodegenerative diseases and brain health affiliated with Hospital Universitario San Ignacio.

He has experience in dementia research, the diagnosis and management of neurodegenerative diseases, and the recruitment and follow-up of research participants. His work focuses on understanding factors associated with cognitive decline, Alzheimer’s disease, and other dementias, with particular attention to the needs of Latin American populations. He has participated in collaborative research initiatives aimed at strengthening scientific evidence and advancing strategies for prevention, care, and brain health research.

SPEAKER

Dr. Irene Meier leads Global Cohort Operations and Strategy at the Davos Alzheimer’s Collaborative (DAC), building research infrastructure and partnerships to expand Alzheimer’s disease research across diverse global populations.

Dr. Irene Meier leads Global Cohort Operations and Strategy at the Davos Alzheimer’s Collaborative (DAC), building research infrastructure and partnerships to expand Alzheimer’s disease research across diverse global populations.

Her work spans Latin America, Africa and Asia, with a focus on cohort development, biomarker access, emerging technologies, and cross population research. She is also leading the development of DAC’s Latin America Brain Health Initiative, which brings together leaders across research, policy, finance, and philanthropy to position brain health as a regional economic and societal priority, and to catalyze investment across Latin America.

SPEAKER

Dr. Nick Cochran is a Faculty Investigator at HudsonAlpha whose research focuses on Alzheimer’s disease and other neurodegenerative disorders. He earned his undergraduate degree at Auburn University, his PhD in Neuroscience at the University of Alabama at Birmingham, and completed a postdoctoral fellowship at HudsonAlpha.

Dr. Nick Cochran is a Faculty Investigator at HudsonAlpha whose research focuses on Alzheimer’s disease and other neurodegenerative disorders. He earned his undergraduate degree at Auburn University, his PhD in Neuroscience at the University of Alabama at Birmingham, and completed a postdoctoral fellowship at HudsonAlpha.

His laboratory combines genetic association studies and functional genomics to understand how genetic diversity influences disease risk, particularly in underrepresented populations. His team also investigates the regulation of genes associated with neurodegeneration to identify potential therapeutic approaches and examines rare non-coding genetic variation to strengthen evidence of its contribution to disease risk.

SPEAKER

Jason Hassenstab, PhD is the Norman J. Stupp Professor of Neurology and Professor of Psychological & Brain Sciences at Washington University in St. Louis.

Jason Hassenstab, PhD is the Norman J. Stupp Professor of Neurology and Professor of Psychological & Brain Sciences at Washington University in St. Louis.

His Cognitive Technology Research Lab (CTRLab) develops digital and remote approaches for measuring cognition in normal aging and neurodegenerative disease. He is Principal Investigator of the ARC-Down Syndrome study, an international study of Down syndrome associated Alzheimer’s disease. He also leads the Cognition Cores for the Knight ADRC, DIAN, and DIAN-TU. He serves as Section Editor for Cognition and Digital Biomarkers for Alzheimer’s & Dementia and Vice Chair of the ISTAART Technology and Dementia PIA.

SPEAKER

Jennifer Yokoyama, PhD, is a Professor in UCSF’s Departments of Neurology and Radiology & Biomedical Imaging. She leads the Alzheimer’s Disease Research Center’s Biomarker Core and is a faculty member at the Global Brain Health Institute.

Jennifer Yokoyama, PhD, is a Professor in UCSF’s Departments of Neurology and Radiology & Biomedical Imaging. She leads the Alzheimer’s Disease Research Center’s Biomarker Core and is a faculty member at the Global Brain Health Institute.

Her research integrates neurogenetics, genomics, transcriptomics, and neuroimaging to understand how genetic variation influences brain function, cognition, and vulnerability or resilience to neurodegeneration, particularly in diverse populations. Her goal is to identify genetic risk factors to inform early treatment and therapeutic interventions. She received the Alzheimer’s Association Excellence in Neuroscience Mentoring Award in 2020 and the Mary Oakley Foundation Professorship in Neurodegeneration in 2021.

SPEAKER

Joaquín Migeot studies social determinants of health, brain ageing, and brain health equity across Latin America. He is an Atlantic Fellow for Equity in Brain Health at the Global Brain Health Institute (GBHI).Joaquín Migeot studies social determinants of health, brain ageing, and brain health equity across Latin America. He is an Atlantic Fellow for Equity in Brain Health at the Global Brain Health Institute (GBHI).

Joaquín Migeot studies social determinants of health, brain ageing, and brain health equity across Latin America. He is an Atlantic Fellow for Equity in Brain Health at the Global Brain Health Institute (GBHI).Joaquín Migeot studies social determinants of health, brain ageing, and brain health equity across Latin America. He is an Atlantic Fellow for Equity in Brain Health at the Global Brain Health Institute (GBHI).

His research integrates exposome science, neuroimaging, biomarkers, and machine learning to understand how structural inequality and lived environments influence brain ageing and dementia risk. Within the ReDLat Consortium, he leads the integration and analysis of social, clinical, cognitive, and neuroimaging data across Latin American countries. He has authored over 25 peer-reviewed publications in journals including Nature Medicine, Nature Communications, and Nature Aging. His work aims to advance equitable brain health and reduce disparities in dementia outcomes.

SPEAKER

Johnny Miller is an artist, photographer and researcher working on inequality. His aerial project Unequal Scenes photographs the world’s most divided cities.

Johnny Miller is an artist, photographer and researcher working on inequality. His aerial project Unequal Scenes photographs the world’s most divided cities.

He is a guest researcher at the Max Planck Institute for Human Development and collaborates with the London School of Economics on links between environment, economics and health. He has published in Nature Medicine and Neuroscience, and currently building AI tools for brain health with a new AI-powered platform “Unequal World”. He co-founded africanDRONE together with Code For Africa: 1,200 pilots in 37 countries in a drone-help network. His book Unequal Scenes (Buchkunst Berlin) appears in October 2026.

SPEAKER

Josefina Cruzat holds a PhD in Theoretical and Computational Neuroscience and master’s degrees in Neuropsychology and Behavioral Neurology, and Brain and Cognition.

Josefina Cruzat holds a PhD in Theoretical and Computational Neuroscience and master’s degrees in Neuropsychology and Behavioral Neurology, and Brain and Cognition.

Her research explores how the brain’s large-scale networks give rise to cognition and mental states, and how these processes break down in disease. She combines behavioral and neuroimaging data with computational mathematical modeling to characterize the biophysical mechanisms underlying brain function. Her work aims to connect cortical network dynamics with states of mind, potentially identifying biomarkers for diagnosis and informing new therapeutic interventions for dysfunctional mental states.

SPEAKER

Dr. Josep Maria Argimon i Pallàs is Director of Health System Relations at the Pasqual Maragall Foundation and the Barcelonaβeta Brain Research Center (BBRC).

Dr. Josep Maria Argimon i Pallàs is Director of Health System Relations at the Pasqual Maragall Foundation and the Barcelonaβeta Brain Research Center (BBRC).

A physician with a doctorate from the Autonomous University of Barcelona, he specializes in Preventive Medicine and Public Health. He holds master’s degrees in Evidence-Based Healthcare from the University of Oxford and in Epidemiology and Health Planning from the University of Wales. His career spans healthcare management, service evaluation, and public health policy. He served as Catalonia’s Minister of Health (2021–2022), Secretary of Public Health, and Managing Director of the Catalan Health Institute. He previously led Catalonia’s Agency for Health Quality and Assessment (AQuAS).

SPEAKER

Dr. Juan Fortea is Director of the Memory Unit within the Neurology Department at Hospital de la Santa Creu i Sant Pau. He is a neurologist specializing in the clinical care and research of neurodegenerative diseases.

Dr. Juan Fortea is Director of the Memory Unit within the Neurology Department at Hospital de la Santa Creu i Sant Pau. He is a neurologist specializing in the clinical care and research of neurodegenerative diseases.

His doctoral research focused on preclinical Alzheimer’s disease, including both sporadic and genetically determined forms. He is the principal investigator of several clinical projects that have generated numerous high-impact publications. He also coordinates the Alzheimer–Down Unit, which has developed a pioneering population screening program for Alzheimer’s disease in adults with Down syndrome in Catalonia.

SPEAKER

Kenneth S. Kosik is a physician-scientist and Harriman Distinguished Professor of Neuroscience and Co-Director of the Neuroscience Research Institute at the University of California, Santa Barbara.

Kenneth S. Kosik is a physician-scientist and Harriman Distinguished Professor of Neuroscience and Co-Director of the Neuroscience Research Institute at the University of California, Santa Barbara.Kenneth S. Kosik is a physician-scientist and Harriman Distinguished Professor of Neuroscience and Co-Director of the Neuroscience Research Institute at the University of California, Santa Barbara.

Previously, he was a Full Professor at Harvard Medical School. His laboratory helped discover tau protein in Alzheimer’s neurofibrillary tangles and characterize its molecular features. His research has also been instrumental in studying large families affected by inherited Alzheimer’s disease in Colombia. He received the 2020 Potamkin Prize and is an elected Fellow of the AAAS. He authored The Alzheimer’s Solution and Outsmarting Alzheimer’s Disease, and his work has been featured in major international media.

SPEAKER

Dr. Takada is a behavioral neurologist, trained at University of Sao Paulo in Brazil and at UCSF Memory and Aging Center, USA (as a visiting scholar).

Dr. Takada is a behavioral neurologist, trained at University of Sao Paulo in Brazil and at UCSF Memory and Aging Center, USA (as a visiting scholar).

He obtained his PhD in 2015, in which he studied monogenic forms of FTD in Brazil. His main research interests are monogenic forms of early-onset dementia (particularly AD and FTD) and the development of apps to improve quality of life in patients with mild cognitive impairment and dementia.

SPEAKER

María Isabel Behrens, MD, PhD, is a neurologist, Full Professor at the University of Chile, and Director of the Center for Advanced Clinical Research (CICA) at its Clinical Hospital.

María Isabel Behrens, MD, PhD, is a neurologist, Full Professor at the University of Chile, and Director of the Center for Advanced Clinical Research (CICA) at its Clinical Hospital.

Her research explores the molecular mechanisms of dementia, particularly the inverse relationship between Alzheimer’s disease and cancer. She leads FONDECYT and FONDEF projects, including a preclinical study investigating a new Alzheimer’s therapy. She has led nine research projects and contributed to fourteen others, with 92 scientific publications. Her work combines translational research, clinical teaching, and graduate supervision. She received the 2019 Medical Research Award and is a corresponding member of the Chilean Academy of Medicine.

SPEAKER

Martin A. Bruno, PhD (McGill University, Montreal, Canada), is an Independent Researcher at CONICET (National Scientific and Technical Research Council, Argentina), Professor of Medicine and Coordinator of the Doctorate in Biomedical Sciences at the Catholic University of Cuyo, San Juan, Argentina.

Martin A. Bruno, PhD (McGill University, Montreal, Canada), is an Independent Researcher at CONICET (National Scientific and Technical Research Council, Argentina), Professor of Medicine and Coordinator of the Doctorate in Biomedical Sciences at the Catholic University of Cuyo, San Juan, Argentina.

He is also Director of the Institute of Biomedical Sciences (ICBM), Faculty of Medical Sciences, at the Catholic University of Cuyo, and Medical Advisor at Biomind Labs. His research focuses on aging, Alzheimer’s disease and other neurodegenerative disorders, with extensive experience in clinical and translational neuroscience. He has supervised numerous doctoral theses and authored dozens of scientific publications in international peer-reviewed journals.

SPEAKER

Michael Schöll is Professor of Molecular Medicine at the University of Gothenburg, Wallenberg Centre for Molecular and Translational Medicine.

Michael Schöll is Professor of Molecular Medicine at the University of Gothenburg, Wallenberg Centre for Molecular and Translational Medicine.

His research focuses on the development and clinical translation of digital, imaging and fluid biomarkers for neurodegenerative disease, combining PET, MRI and blood-based measures to identify pathological processes as early as possible and to distinguish them from healthy ageing. He is among the highest-cited researchers in the field, a member of the Young Academy of Sweden, BrainPool Fellow of the Korean Academy of Sciences, and founder of the international UCL/University of Gothenburg doctoral course on biomarkers for neurodegenerative diseases.

SPEAKER

Nahuel Magrath Guimet, MD is a neuropsychiatrist in the Department of Cognitive Neurology, Neuropsychology and Neuropsychiatry at Fleni (Buenos Aires, Argentina), where he also directs the Frontotemporal Dementia Clinic.

Nahuel Magrath Guimet, MD is a neuropsychiatrist in the Department of Cognitive Neurology, Neuropsychology and Neuropsychiatry at Fleni (Buenos Aires, Argentina), where he also directs the Frontotemporal Dementia Clinic.

He is an Atlantic Fellow at the Global Brain Health Institute (GBHI, UCSF), Site Principal Investigator for the ReDLat consortium at Fleni, and Associate Editor of npj Dementia. His research focuses on behavioral-onset dementias, their biomarkers, and their genetics in Latin America.

SPEAKER

Dr. Nilton Custodio is a neurologist and Medical Director of the Instituto Peruano de Neurociencias in Lima, Peru. His research focuses on neurodegenerative diseases in underserved populations, including people with limited formal education and Aymara and Quechua communities.

Dr. Nilton Custodio is a neurologist and Medical Director of the Instituto Peruano de Neurociencias in Lima, Peru. His research focuses on neurodegenerative diseases in underserved populations, including people with limited formal education and Aymara and Quechua communities.

A Fellow of the American Academy of Neurology and former President of the Peruvian Society of Neurology, he has authored over 200 scientific publications. His research has received support from the Alzheimer’s Association, NIH/National Institute on Aging, and UK Medical Research Council. He is a founding member of the Latin American and Caribbean Consortium on Dementia (LAC-CD) and leads regional initiatives including ReDLat, GAPP, LatAm FINGERS, GLASS-AD, and IMPACT.

SPEAKER

Nisha Sajnani is an Associate Professor and Director of the NYU Steinhardt Graduate Program in Drama Therapy, Chair of the NYU Creative Arts Therapies Consortium, and Founder of Arts & Health @ NYU.

Nisha Sajnani is an Associate Professor and Director of the NYU Steinhardt Graduate Program in Drama Therapy, Chair of the NYU Creative Arts Therapies Consortium, and Founder of Arts & Health @ NYU.

Other faculty appointments include NYU Abu Dhabi, where she developed the trans-disciplinary course Can Art Save Lives?, uniting current evidence for the health benefits of the arts with practice and policy; the NYU Stern School of Business, where she teaches improvisation and leadership; and the Harvard Program in Refugee Trauma, where she lectures on the role of the arts in supporting the wellbeing of people who are forcibly displaced.

SPEAKER

Rufus Olusola Akinyemi, MBBS, MSc, PhD, is a Professor in the Neuroscience and Ageing Research Unit at the University of Ibadan, Nigeria, and Deputy Director of its Centre for Genomic and Precision Medicine.

Rufus Olusola Akinyemi, MBBS, MSc, PhD, is a Professor in the Neuroscience and Ageing Research Unit at the University of Ibadan, Nigeria, and Deputy Director of its Centre for Genomic and Precision Medicine.

He is a consultant neurologist at University College Hospital, Ibadan, and a Senior Fellow at the Global Brain Health Institute, Trinity College Dublin. He is also a FLAIR Research Fellow supported by the African Academy of Sciences and the UK Royal Society, and a member of Newcastle University’s Neurovascular Research Group. He serves on the International Stroke Genetics Consortium’s Steering Committee and is the founding Chair of the African Stroke Organization’s Steering Committee.

SPEAKER

Sandra Báez is an Associate Professor in the Department of Psychology at Universidad de los Andes and a Senior Atlantic Fellow for Equity in Brain Health at the Global Brain Health Institute.

Sandra Báez is an Associate Professor in the Department of Psychology at Universidad de los Andes and a Senior Atlantic Fellow for Equity in Brain Health at the Global Brain Health Institute.

Her research examines how poverty, inequality, and violence affect brain health and ageing in vulnerable populations. She has published over 100 articles in high-impact scientific journals, including Nature Medicine and JAMA Neurology. Her work has received prestigious awards, including the L’Oréal-UNESCO For Women in Science Award (Colombia, 2019). She has also contributed to the development of innovative interventions to improve the well-being of caregivers of people living with dementia.

SPEAKER

Simone Cecchini is Director of CELADE – Population Division of the ECLAC, whose mission is to strengthen countries’ capacities to analyze population dynamics and to include demographic factors into public policies.

Simone Cecchini is Director of CELADE – Population Division of the ECLAC, whose mission is to strengthen countries’ capacities to analyze population dynamics and to include demographic factors into public policies.

He joined the ECLAC in 2002, where he held positions in the Office of the Secretary of the Commission, the Statistics Division and the Social Development Division. Between 1998 and 2002 he worked with the World Bank’s Poverty Group. He holds a Degree in Political Science from the University of Florence, where he graduated with honors with a thesis in demography; an MA in International Trade and Investment Policy from George Washington University; and an MBA from Universidad Católica of Chile.

 MODERATOR

Stefanie earned her medical degree in Mexico City, where she subsequently completed her residency in Internal Medicine and fellowship training in Geriatrics.

Stefanie earned her medical degree in Mexico City, where she subsequently completed her residency in Internal Medicine and fellowship training in Geriatrics.

She later moved to the United States to complete the Atlantic Fellowship at the UCSF Memory and Aging Center. She went on to earn a Master of Science in UCSF’s Pharmaceutical Sciences and Pharmacogenomics program and is currently completing her PhD in the same program. Her research focuses on understanding how genomic diversity influences neurodegenerative diseases in admixed populations, with the goal of advancing a more representative understanding of the genetic architecture of these disorders. She serves as the Scientific Lead of the Multi-Partner Consortium to Expand Dementia Research in Latin America (ReDLat).

SPEAKER

Dr. Temitope Farombi is a Consultant Geriatric Neurologist, researcher, and brain health advocate committed to transforming how Africa understands, prevents, and cares for neurological disorders.

Dr. Temitope Farombi is a Consultant Geriatric Neurologist, researcher, and brain health advocate committed to transforming how Africa understands, prevents, and cares for neurological disorders.

She combines clinical practice, research, digital health, and community engagement to expand access to quality brain healthcare, particularly for older adults. She is the founder of Brain Center and Brain Health Initiative Nigeria and a Senior Atlantic Fellow of the Global Brain Health Institute. Her work spans dementia, stroke, Parkinson’s disease, critical neurology, rehabilitation, and lifelong brain health, with a growing focus on building innovative, equitable brain-health solutions for Africa.

ABOUT THE EVENT

The ReDLat Annual Meeting will mark the official launch of ReDLat2, a new phase of the international scientific consortium established to expand and transform research on dementia and other neurodegenerative diseases in Latin America.

ReDLat2 seeks to understand why individuals with similar biological risks can follow very different aging and disease trajectories depending on the environments in which they live. It examines how the exposome—social, environmental, and cultural conditions—interacts with genetics, leaving biological signatures in the epigenome and other mechanisms that aging clocks can capture. By integrating genetics, epigenetics, neuroimaging, biomarkers, cognition, language, and circadian rhythms, ReDLat2 leverages Latin America’s extraordinary diversity to understand how genes and environments shape aging together.

The meeting will bring together researchers, academic and institutional leaders, healthcare sector representatives, international organizations, foundations, and collaborators from different countries. It will provide a space to share progress across ReDLat2 and its associated initiatives, examine key challenges in brain health research, and foster new partnerships among academia, healthcare systems, the public sector, industry, and philanthropy.

More than a scientific meeting, this event aims to strengthen an international collaborative platform that can generate more diverse and representative knowledge, expand research capacity across the region, and support the development of better strategies to understand, diagnose, and prevent neurodegenerative diseases.